4//SEC Filing
LIVINGSTON RANDALL S 4
Accession 0001299130-21-000053
CIK 0001299130other
Filed
Feb 16, 7:00 PM ET
Accepted
Feb 17, 9:17 PM ET
Size
16.1 KB
Accession
0001299130-21-000053
Insider Transaction Report
Form 4
LIVINGSTON RANDALL S
Director
Transactions
- Exercise/Conversion
Common Stock
2021-02-12$10.58/sh+17,500$185,150→ 17,500 total - Exercise/Conversion
Stock Option (right to buy)
2021-02-12−17,500→ 0 totalExercise: $10.58Exp: 2021-06-23→ Common Stock (17,500 underlying) - Exercise/Conversion
Stock Option (right to buy)
2021-02-12−25,000→ 0 totalExercise: $1.83Exp: 2022-06-13→ Common Stock (25,000 underlying) - Exercise/Conversion
Stock Option (right to buy)
2021-02-12−25,000→ 0 totalExercise: $2.54Exp: 2023-05-21→ Common Stock (25,000 underlying) - Exercise/Conversion
Common Stock
2021-02-12$1.83/sh+25,000$45,750→ 42,500 total - Exercise/Conversion
Common Stock
2021-02-12$2.54/sh+25,000$63,500→ 67,500 total - Sale
Common Stock
2021-02-12$48.07/sh−67,500$3,244,455→ 0 total
Footnotes (2)
- [F1]This sale price represents the weighted average sale price of the shares sold ranging from $48.00 to $48.70 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
- [F2]The shares subject to the option are fully vested and exercisable.
Documents
Issuer
PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
CIK 0001299130
Entity typeother
Related Parties
1- filerCIK 0001235118
Filing Metadata
- Form type
- 4
- Filed
- Feb 16, 7:00 PM ET
- Accepted
- Feb 17, 9:17 PM ET
- Size
- 16.1 KB